Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Trial of Vaccine Therapy With mRNA- Transfected Dendritic Cells in Patients With Advanced Malignant Melanoma

NCT01278940 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.

NCT NCT01278940
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01278940 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Trial of Vaccine Therapy With mRNA- Transfected Dendritic Cells in Patients With Advanced Malignant Melanoma
Lead sponsor
Oslo University Hospital
Phase
Phase 1/2
Overall status
Completed
Start date
March 31, 2002
Completion date
December 31, 2015
Enrollment
31 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

malignant melanoma